Seeing Is Believing

Currently out of the existing stock ratings of Emily Field, 21 are a HOLD (30.88%), 36 are a BUY (52.94%), 11 are a SELL (16.18%).
Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 51.96% that have a potential upside of 19.04% achieved within 219 days.
Emily Field’s has documented 124 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.
Most recent stock forecast was given on BIIB, Biogen.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 12/21/2023. The price target of $361.87 was fulfilled within 1 day with a profit of $7.74 (2.19%) receiving and performance score of 21.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Apr-2023
$1232
$349.52 (39.61%)
$1182
Buy Since 17-Jul-2023
$1090
$207.52 (23.52%)
$1078
Buy Since 17-Jul-2023
$1120
$237.52 (26.92%)
$1185
Buy Since 18-Aug-2026
$1190
$307.52 (34.85%)
$1250
Buy Since 14-Sep-2018
$1336
$453.52 (51.39%)
$1356
Which stock is Emily Field most bullish on?
Which stock is Emily Field most reserved on?
What Year was the first public recommendation made by Emily Field?